Novel Somatic Variants in Ctnna1 Gene in Iranian Patients With Diffuse Gastric Cancer Publisher



Vishteh MN¹ ; Salmani TA² ; Mamaghani AJ³ ; Tabaei SJS⁴ ; Kheirollahi M¹ Show Affiliations
Source: Gastroenterology and Hepatology from Bed to Bench Published:2021

Abstract

Aim: we aimed to evaluate somatic mutations of CTNNA1 in DGC patients. Background: Diffuse gastric cancer (DGC) is a major type of gastric cancer where most cases are sporadic diffuse gastric cancer (SDGC). It has been shown that mutations in CTNNA1 are responsible for some cases of hereditary diffuse gastric cancer (HDGC). Methods: In the present work, 48 formalin-fixed paraffin-embedded tissues, including samples of 38 SDGC and 10 HDGC patients were examined through Sanger sequencing approach on PCR products amplified from 18 exons and boundaries of intron/exon of CTNNA1 gene. Results: We revealed 9 novel somatic mutations in CTNNA1 gene in patients with HDGC and SDGC, from which one variant was intronic. Eight patients had at least one disease-causing mutation (16.6%). Most of the patients were in the III stage of cancer (50%). Except for one patient, histological type of the rest of mutation-harboring patients was signet ring cell carcinoma, and only one HDGC patient had CTNNA1 mutation. Conclusion: Our study showed several novel variants in the CTNNA1 gene in Iranian sporadic and hereditary DGC patients, and implies that the CTNNA1 gene mutations could be involved in the pathogenesis of DGC, either hereditary or in sporadic cases. ©2021 RIGLD, Research Institute for Gastroenterology and Liver Diseases.